Senate
House
Joint
Bill Status
WV Code
Audits/ Reports
Educational
Contact
home
home

Introduced Version Senate Bill 162 History

DOWNLOAD  wpd  |  Email


sb162 intr
Senate Bill No. 162

(By Senator Carmichael)

____________

         [Introduced February 14, 2013; referred to the Committee on Health and Human Resources; and then to the Committee on the Judiciary          .]                            

____________




A BILL to amend and reenact §60A-2-206 and §60A-2-208 of the Code of West Virginia, 1931, as amended, all relating to reclassifying hydrocodone from a Schedule III controlled substance to a Schedule II controlled substance.
Be it enacted by the Legislature of West Virginia:
    That §60A-2-206 and §60A-2-208 of the Code of West Virginia, 1931, as amended, be amended and reenacted, all to read as follows:
ARTICLE 2. STANDARDS AND SCHEDULES.
§60A-2-206. Schedule II.
    (a) Schedule II consists of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.
    (b) Substances, vegetable origin or chemical synthesis. -- Unless specifically excepted or unless listed in another schedule, any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:
    (1) Opium and opiate, and any salt, compound, derivative or preparation of opium or opiate excluding apomorphine, thebaine- derived butorphanol, dextrorphan, nalbuphine, nalmefene, naloxone and naltrexone, and their respective salts, but including the following:
    (A) Raw opium;
    (B) Opium extracts;
    (C) Opium fluid;
    (D) Powdered opium;
    (E) Granulated opium;
    (F) Tincture of opium;
    (G) Codeine;
    (H) Ethylmorphine;
    (I) Etorphine hydrochloride;
    (J) Hydrocodone;
    (K) Hydromorphone;
    (L) Metopon;
    (M) Morphine;
    (N) Oxycodone;
    (O) Oxymorphone;
    (P) Thebaine;
    (2) Any salt, compound, derivative or preparation thereof which is chemically equivalent or identical with any of the substances referred to in subdivision (1) of this subsection, except that these substances shall not include the isoquinoline alkaloids of opium;
    (3) Opium poppy and poppy straw;
    (4) Coca leaves and any salt, compound, derivative or preparation of coca leaves (including cocaine and ecgonine and their salts, isomers, derivatives and salts of isomers and derivatives), and any salt, compound, derivative or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include decocainized coca leaves or extractions of coca leaves, which extractions do not contain cocaine or ecgonine;
    (5) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy).
    (c) Opiates. -- Unless specifically excepted or unless in another schedule, any of the following opiates, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation, dextrorphan and levopropoxyphene excepted:
    (1) Alfentanil;
    (2) Alphaprodine;
    (3) Anileridine;
    (4) Bezitramide;
    (5) Bulk dextropropoxyphene (nondosage forms);
    (6) Carfentanil;
    (7) Dihydrocodeine;
    (8) Diphenoxylate;
    (9) Fentanyl;
    (10) Isomethadone;
    (11) Levo-alphacetylmethadol; some other names: levo-alpha- acetylmethadol, levomethadyl acetate, LAAM;
    (12) Levomethorphan;
    (13) Levorphanol;
    (14) Metazocine;
    (15) Methadone;
    (16) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4- diphenyl butane;
    (17) Moramide-Intermediate, 2-methyl-3-morpholino-1,
1-diphenylpropane-carboxylic acid;
    (18) Pethidine; (meperidine);
    (19) Pethidine-Intermediate-A, 4-cyano-1-methyl-4- phenylpiperidine;
    (20) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4- carboxylate;
    (21) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4- carboxylic acid;
    (22) Phenazocine;
    (23) Piminodine;
    (24) Racemethorphan;
    (25) Racemorphan;
    (26) Remifentanil;
    (27) Sufentanil.
    (d) Stimulants. -- Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:
    (1) Amphetamine, its salts, optical isomers and salts of its optical isomers;
    (2) Hydrocodone, its salts, optical isomers and salts of its optical isomers;
____
(2) (3) Methamphetamine, its salts, isomers and salts of its isomers;
    (3) (4) Methylphenidate;
    (4) (5) Phenmetrazine and its salts.
    (e) Depressants. -- Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
    (1) Amobarbital;
    (2) Glutethimide;
    (3) Pentobarbital;
    (4) Phencyclidine;
    (5) Secobarbital.
    (f) Hallucinogenic substances:
    Nabilone: [Another name for nabilone: (+-)-trans-3-(1, 1- dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1-hydroxy-6, 6- dimethyl-9H-dibenzo [b,d] pyran-9-one].
    (g) Immediate precursors. -- Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:
    (1) Immediate precursor to amphetamine and methamphetamine:
    (A) Phenylacetone;
    Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;
    (2) Immediate precursors to phencyclidine (PCP):
    (A) 1-phenylcyclohexylamine;
    (B) 1-piperidinocyclohexanecarbonitrile (PCC).
§60A-2-208. Schedule III.
    (a) Schedule III consists of the drugs and other substances, by whatever official name, common or usual name, chemical name or brand name designated, listed in this section.
    (b) Stimulants. -- Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position or geometric), and salts of such isomers whenever the existence of the salts, isomers and salts of isomers is possible within the specific chemical designation:
    (1) Those compounds, mixtures or preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures or preparations were listed on August 25, 1971, as excepted compounds under 21 C.F.R §1308.32, and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances;
    (2) Benzphetamine;
    (3) Chlorphentermine;
    (4) Clortermine;
    (5) Phendimetrazine.
    (6) Hydrocodone.
    (c) Depressants. -- Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:
    (1) Any compound, mixture or preparation containing:
    (A) Amobarbital;
    (B) Secobarbital;
    (C) Pentobarbital; or any salt of pentobarbital and one or more other active medicinal ingredients which are not listed in any schedule;
    (2) Any suppository dosage form containing:
    (A) Amobarbital;
    (B) Secobarbital;
    (C) Pentobarbital; or any salt of any of these drugs and approved by the food and drug administration for marketing only as a suppository;
    (3) Any substance which contains any quantity of a derivative of barbituric acid or any salt of barbituric acid;
    (4) Chlorhexadol;
    (5) Lysergic acid;
    (6) Lysergic acid amide;
    (7) Methyprylon;
    (8) Sulfondiethylmethane;
    (9) Sulfonethylmethane;
    (10) Sulfonmethane;
    (11) Tiletamine and zolazepam or any salt of tiletamine and zolazepam; some trade or other names for a tiletamine-zolazepam combination product: Telazol; some trade or other names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone; some trade or other names for zolazepam: 4-(2-flurophenyl)-6, 8-dihydro-1, 3, 8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one, flupyrazapon;
    (12) Human growth hormones or anabolic steroids.
    Ketamine, its salts, isomers and salts of isomers, including ketamine hydrochloride.
    (d) Nalorphine.
    (e) Narcotic drugs. -- Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:
    (1) Not more than 1.8 grams of codeine per 100 milliliters and not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;
    (2) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
    (3) Not more than 300 milligrams of dihydrocodeinone (hydrocodone) per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium;
    (4) Not more than 300 milligrams of dihydrocodeinone (hydrocodone) per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
    (5) Not more than 1.8 grams of dihydrocodeine per 100 milliliters and not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
    (6) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
    (7) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
    (8) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
    (f) Anabolic steroids. -- Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of anabolic steroids, including its salts, isomers and salts of isomers whenever the existence of the salts of isomers is possible within the specific chemical designation.
    (g) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States food and drug administration approved drug product. (Some other names for dronabinol: (6aR-trans)-6a, 7, 8, 10a- tetrahydro-6, 6, 9- trimethyl-3-pentyl-6H-dibenzo [b,d] pyran-1- ol or (-)-delta-9- (trans)-tetrahydrocannabinol).


         
    NOTE: The purpose of this bill is to reclassify hydrocodone from being a Schedule III controlled substance to a Schedule II controlled substance.


    Strike-throughs indicate language that would be stricken from the present law, and underscoring indicates new language that would be added.
This Web site is maintained by the West Virginia Legislature's Office of Reference & Information.  |  Terms of Use  |   Web Administrator   |   © 2014 West Virginia Legislature **